KYNB
Kyntra Bio, Inc.
NASDAQ: KYNB · HEALTHCARE · BIOTECHNOLOGY
$7.27
+3.12% today
Updated 2026-04-30
Market cap
$28.37M
P/E ratio
—
P/S ratio
4.41x
EPS (TTM)
$-14.40
Dividend yield
—
52W range
$5 – $13
Volume
0.0M
Kyntra Bio, Inc. (KYNB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-60.1%
Last 4 quarters
Revenue YoY growth
-101.0%
Most recent quarter
EPS YoY growth
-2050.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-9.9%
2025-11-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-17 | $-3.51 | +9.7% | $7.00 | $7.05 | +0.7% |
| 2025-11-10 | $-3.25 | -3321.1% | $11.03 | $9.94 | -9.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-3.89 | $-3.51 | +9.7% | $1.28M | -101.0% |
| 2025-09-30 | $-0.10 | $-3.25 | -3321.1% | $1.08M | -97.7% |
| 2025-06-30 | $-0.09 | $-3.39 | -3666.7% | $1.35M | +35.1% |
| 2025-03-31 | $-0.10 | $0.05 | +150.0% | $2.74M | -89.2% |
| 2024-12-31 | $-0.17 | $0.18 | +205.9% | $-123.26M | -554.2% |
| 2024-09-30 | $-0.31 | $-0.17 | +45.2% | $46.33M | +15.4% |
| 2024-06-30 | $-0.32 | $-0.16 | +50.0% | $998000.00 | -97.7% |
| 2024-03-31 | $-0.41 | $-0.33 | +19.5% | $25.36M | -29.9% |
| 2023-12-31 | $-0.44 | $-0.57 | -29.5% | $27.14M | — |
| 2023-09-30 | $-0.68 | $-0.65 | +4.4% | $40.13M | — |
| 2023-06-30 | $-0.70 | $-0.90 | -28.6% | $44.32M | — |
| 2023-03-31 | $-0.75 | $-0.81 | -8.0% | $36.16M | — |
Frequently asked questions
Has Kyntra Bio, Inc. beaten earnings estimates?
Kyntra Bio, Inc. has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -60.1% over the last 4 quarters.
How does KYNB stock react to earnings?
KYNB stock has moved an average of -4.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Kyntra Bio, Inc.'s revenue growth rate?
Kyntra Bio, Inc. reported year-over-year revenue growth of -101.0% in its most recent quarter, with EPS growing -2050.0% year-over-year.